Stroke, Vol 23, 725-732, Copyright © 1992 by American Heart Association
Combination therapy with nimodipine and dizocilpine in a rat model of transient forebrain ischemia
MR Rod and RN Auer
Department of Pathology, University of Calgary, Alberta, Canada.
BACKGROUND AND PURPOSE: We explored the effectiveness of dual blockade of
calcium channels in preventing ischemic necrosis in a rat model of
transient forebrain ischemia. METHODS: To assess all the major brain
regions, the entire brain was subserially sectioned and examined
histologically 1 week after ischemia in 44 male Wistar rats. Brain
temperature was monitored and controlled to avoid hypothermia or intergroup
temperature differences at the time drugs were administered. All regimens
were begun 20 minutes after ischemia. Treated animals received either the
L-type calcium channel blocker nimodipine (0.25 microgram/min x 24-hour
i.v. infusion), the noncompetitive N-methyl-D- aspartate receptor
antagonist MK-801 (dizocilpine; 5 mg/kg i.v.), or both regimens in
combination. RESULTS: In the neocortex (p less than 0.05) and striatum (p
less than 0.05), only double-treated animals showed a statistically
significant reduction in neuronal necrosis. Dual therapy eliminated
neuronal necrosis in the caudate nucleus entirely. In the septal (densely
ischemic) hippocampus, protection was weak and inconsistent (0.012 less
than p less than 0.788), but in the temporal (incompletely ischemic)
hippocampus, the dual-treated group showed the most significant reduction
(p less than 0.006). CONCLUSIONS: We conclude that the combination of
nimodipine and MK-801, if begun 20 minutes after ischemia, may offer a
neuroprotective effect against neuronal necrosis in transient forebrain
ischemia and that protection is maximal in the major extrahippocampal brain
regions.